JP Morgan Maintains Overweight on Merit Medical Systems, Lowers Price Target to $77

Benzinga Newsdesk www.benzinga.com Negative 83.6%

Neg 83.6% Neu 0% Pos 0%

JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and lowers the price target from $95 to $77.